Novo Nordisk Pharmatech and Novozymes enter into enzyme partnership

Going forward, Novo Nordisk Pharmatech and Novozymes will collaborate on developing enzymes to be used in biotechnological drug development.

Photo: Novo Nordisk Pharmatech/PR

Novo Nordisk Pharmatech and Novozymes have partnered up to developed specialty enzymes meant for biopharma processing and regenerative medicines, the firms announce in a shared press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs